Staar Surgical reported $49.26M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6908M 160M
Atrion ATRI:US 17.38M 414K
Boston Scientific BSX:US $ 2059M 85M
Cerus CERS:US $ 24.94M 5.67M
Cooper Companies COO:US $ 532.5M 14.1M
Exact Sciences EXAS:US $ 351.87M 2.89M
Hologic HOLX:US $ 946.6M 39.7M
Johnson & Johnson JNJ:US $ 15828M 1021M
Meridian Bioscience VIVO:US $ 68.48M 19.32M
Merit Medical Systems MMSI:US $ 120.91M 7.9M
Novartis NOVN:VX 9.06B 463M
Orasure Technologies OSUR:US $ 24.27M 2.86M
Orthofix International OFIX:US $ 78.1M 13.71M
Sientra SIEN:US 12.84M 518K
Staar Surgical STAA:US $ 49.26M 4.27M
Utah Medical Products UTMD:US 8.07M 1.13M
Valeant Pharmaceuticals VRX:CN $ 1367M 203M